XML 14 R4.htm IDEA: XBRL DOCUMENT v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF NET INCOME (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 28, 2024
Sep. 30, 2023
Sep. 28, 2024
Sep. 30, 2023
Income Statement [Abstract]        
Net sales $ 567,390 $ 607,071 $ 1,661,263 $ 1,828,850
Cost of sales 351,498 380,200 1,050,559 1,122,190
Gross profit 215,892 226,871 610,704 706,660
Selling, general, and administrative expenses 83,897 87,204 263,395 270,057
Research and development expenses 26,470 25,484 81,283 77,270
Amortization of intangibles 15,864 16,022 47,418 49,773
Restructuring, impairment, and other charges 1,840 4,516 10,329 13,221
Total operating expenses 128,071 133,226 402,425 410,321
Operating income 87,821 93,645 208,279 296,339
Interest expense 9,772 10,101 29,358 29,803
Foreign exchange loss 9,630 11,776 4,273 8,697
Other income, net (9,297) (3,527) (19,916) (11,810)
Income before income taxes 77,716 75,295 194,564 269,649
Income taxes 19,658 17,507 42,588 53,045
Net income $ 58,058 $ 57,788 $ 151,976 $ 216,604
Earnings per share:        
Basic (in dollars per share) $ 2.34 $ 2.32 $ 6.12 $ 8.72
Diluted (in dollars per share) $ 2.32 $ 2.30 $ 6.07 $ 8.63
Weighted-average shares and equivalent shares outstanding:        
Basic (in shares) 24,796 24,893 24,822 24,838
Diluted (in shares) 25,025 25,143 25,040 25,100